Cancer Archives

An Open Access, Peer Reviewed Journal
Impact-Factor: 0.00*
Online ISSN: 2633-1438

Volume 01, Issue 02


Peripheral T-cell lymphoma activation on nivolumab for oesophageal cancer

Ian S Boon Jean S Lim Karen H Williams Kathleen E Romain Tracy PT Au Yong Cheng S Boon

Case Report-Cancer Archives

August 22, 2019


Elaboration of EQID tool for digestive cancer predisposition

Souria Aissaoui Stéphane Pinson Sophie Giraud Marisa Raymond Hagay Sobol Alain Calender

Research article-Cancer Archives

August 25, 2019


Spontaneous regression of angiosarcoma

Mike T Wei Ganesh M Shankar Scott A Ely Roger J Bartolotta Andre-Pascal Sappino David N Posnett

Research Article-Cancer Archives

September 09, 2019


About Journal


The Cancer Archives is an open access journal with comprehensive peer review policy and a rapid publication process. Cancer Archives is a novel, highly innovative and progressive journal which focuses upon our understanding of cancer research, cancer prevention, translational research, environment and cancer, lifestyle and cancer, pharmacology and pharmacogenomics aspects, cancer treatments, elderly cancer patients, virus-related tumours, cancer survivorship, psycho-oncology, innovative aspects regarding diagnosis, pathology, clinical-experimental oncology.

Cancer Archives is composed of the following Specialty Sections:

Cancer Science

Leukemia

Cancer Therapies

Lungs Cancer

Blood Cancer

Lymphoma Cancer

Bone Marrow Cancer

Molecular Oncology

Brain Cancer

Myleloid Leukemia

Breast Cancer

Ovarian Cancer

Carcinogenesis

Pancreatic Cancer

Carcinoid Tumours

Radiation Oncology

Cervical Cancer

Throat Cancer

Duodenal Cancer

Thyroid Cancer

Genitourinary Oncology

Skin Cancer

Oseophagus Cancer

Sarcoma Cancer

Cancer Biology

Cellular Oncology

Cancer Archives journal aims to deliver an exchange forum for the researchers to publish their results in oncologic disciplines. Cancer Archives covers basic, translational and clinical research in a vast range of cancer related topics. The list is endless, so we hope that Cancer Archives will become a vehicle for all those interested in advancing the field in all its different forms.

Cancer Archives will feature original research, review papers, clinical studies, editorials, expert opinion and perspective papers, commentaries, book reviews and meeting reports.

Cancer Archives welcomes direct submissions from authors: Attach your word file with e- mail and send it to submissions@oatext.com

Please, follow the Instructions for Authors. In the cover letter add the name and e-mail address of 5 proposed reviewers (we can choose them or not).

Copyright is retained by the authors and articles can be freely used and distributed by others. Articles are distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published by Cancer Archives, is properly cited.

Dr J A Z Jankowski


Professor Janusz Jankowski is an author, doctor, educationalist and scientist. He is an expert in Social and Healthcare Policy, Academic Management and Global Research and Education Networks. He was formerly in previous senior management roles including Deputy Vice Chancellor, Pro Vice Chancellor, Dean for Research and the Sir James Black Professorship.

He graduated from the University of Glasgow with MBChB (1983), an MD at the University of Dundee (1996), a PhD Imperial College London (1996) and an MSc at the University of Oxford  (2009).

Prof Jankowski was an editor of text books in gastroenterology and gastrointestinal cancer and has been on the editorial board of several high impact journals and was the editor-in-chief of Gastrointestinal Oncology.

Prof Jankowski's group have undertaken several studies including the isolation of label retaining cells (putative stem cells) in the oesophagus, identification of the genomic factors associated with the premalignant condition Barrett's oesophagus. Jankowski has studied the use of aspirin and proton pump inhibitors in one of the largest randomized clinical trials to prevent cancer. Prof Jankowski has also published independent guidance for the National Health Service (NHS) and other international organisations using the Delphi systematic review platforms. Prof Jankowski is a highly cited clinical academic with a h-index of over 68.

Editor-in-Chief


Dr J A Z Jankowski

University Morecambe Bay Hospitals Trust, UK

Read more

Editorial Board.


Mohammad R.N. Avanaki

Assistant Professor
Department of Biomedical Engineering
Wayne State University
USA

Hridayesh Prakash

Associate Professor
Institute of Virology and Immunology
Amity University
India

Yasemin Benderli Cihan

Department of Radiation Oncology
Kayseri Education and Research Hospital
Turkey


Silvia E Hajos

Professor
Department of Immunology
University of Buenos Aires
Argentina

Yangchao Chen

Associate Professor
School of Biomedical Sciences
Chinese University of Hong Kong
Hong Kong

Barbara Adinolfi

Researcher
National Research Center
Italy


Cezary Szczylik

Department of Oncology
Military Institute of Medicine
Poland

Hong XUE

Division of Life Science
Hong Kong University of Science and Technology
PR China

Alessia Castellino

Department of Hematology
AO Santa Croce and Carle Hospital of Cuneo
Italy


You Zhang

Department of Radiation Oncology
The University of Texas Southwestern Medical Center
USA

Alfio Ferlito

Professor
Department of Otorhinolaryngology-Head and Neck Surgery
Udine University Faculty of Medicine
Italy

Preethi Ramachandran

Division of Hematology/Oncology
Brookdale University Hospital Medical Center
USA


Maria Grazia Perrone

Department of Pharmacy
Pharmaceutical Sciences
University of Bari
Italy

Maciej Socha

Department of Obstetrics, Gynecology and Gynecological Oncology
Faculty of Medicine
Nicolaus Copernicus University
Poland

Ying-Chien Chung

Professor
Department of Biological Science and Technology
China University of Science and Technology
Taiwan


Daniel Timofte

Medical Director
Sf. Spiridon University Hospital
Romania

Luisa Carlota Lopez Cara

Associate Professor
Department of Pharmacy
University of Granada
Spain

Murat Serilmez

Department of Basic Oncology
Istanbul University
Turkey


Bora UYSAL

Associate Professor
Department of Radiation Oncology
Gulhane Military Medical Academy
Turkey

Ian S Boon

Department of Clinical Oncology
Leeds Cancer Centre
St James's Institute of Oncology
Leeds Teaching Hospitals NHS Trust
UK

Gynaecological Oncology Research Group

Laboratory for Cell and Protein Regulation
Department of Obstetrics & Gynaecology
University of Otago
USA

In Press


will be updated soon.

Current Issue

Volume 1, Issue 2


Peripheral T-cell lymphoma activation on nivolumab for oesophageal cancer

Ian S Boon Jean S Lim Karen H Williams Kathleen E Romain Tracy PT Au Yong Cheng S Boon

Case Report-Cancer Archives

August 22, 2019


Elaboration of EQID tool for digestive cancer predisposition

Souria Aissaoui Stéphane Pinson Sophie Giraud Marisa Raymond Hagay Sobol Alain Calender

Research article-Cancer Archives

August 25, 2019


Spontaneous regression of angiosarcoma

Mike T Wei Ganesh M Shankar Scott A Ely Roger J Bartolotta Andre-Pascal Sappino David N Posnett

Research Article-Cancer Archives

September 09, 2019


Archive


Volume 1

Peripheral T-cell lymphoma activation on nivolumab for oesophageal cancer

Ian S Boon Jean S Lim Karen H Williams Kathleen E Romain Tracy PT Au Yong Cheng S Boon

Case Report-Cancer Archives

August 22, 2019


Elaboration of EQID tool for digestive cancer predisposition

Souria Aissaoui Stéphane Pinson Sophie Giraud Marisa Raymond Hagay Sobol Alain Calender

Research article-Cancer Archives

August 25, 2019


Spontaneous regression of angiosarcoma

Mike T Wei Ganesh M Shankar Scott A Ely Roger J Bartolotta Andre-Pascal Sappino David N Posnett

Research Article-Cancer Archives

September 09, 2019


The implication of cancer regression by the interactions with human anatomical axes – an active prevention for cancer

Ming Cheh Ou Dennis Ou Chung Chu Pang

Case Report-Cancer Archives

April 15, 2019


The global cancer burden

Rebecca Willans Janusz Jankowski

Mini Review-Cancer Archives

May 24, 2019


Diagnostic, genetic and therapeutic challenges in mixed phenotype acute leukemia: a case report

Noran Qawasmeh Mohammed Abu-Rayyan Mamdouh Skafi Moien Atrash Ibrahim Yaghmour Ahlam Mujahed Hamdi Al-Janazreh Hamdi Al-Janazreh

Case Report-Cancer Archives

June 03, 2019


C

Submit Manuscript


Cancer Archives welcomes direct submissions from authors: Attach your word file with e- mail and send it to submissions@oatext.com

Publication Charges


Cancer Archives is an Open Access journal and we do not charge the end user when accessing a manuscript or any article. This allows the scientific community to view, download, distribution of an article in any medium, provided that the original work is properly cited, under the term of "Creative Commons Attribution License". In line with other open access journals we provide a flat fee submission structure on the acceptance of a peer-reviewed article which covers in part the entirety of the publication pathway (the article processing charge). The process includes our maintenance, submission and peer review systems and international editing, publication and submission to global indexing and tracking organisations and archiving to allow instant access to the whole article and associated supplementary documents. We also have to ensure enough investment to secure a sustainable model which ethically, legally and financially stable.

The publication charges for Cancer Archives are GBP 1280.

Frequently Asked Questions (FAQs)

Why are your charges set at these levels?

All articles published in OA Text are open access. Open Access publishing implies that all readers, anywhere in the world, are allowed unrestricted to full text of articles, immediately on publication in OA Text Journals. The Article Publication Charges pay for the editorial and production costs of the journal, for hosting the website, publishing articles online, preparing HTML , PDF and XML versions of the articles and submitting the articles in electronic citation database like CrossRef.

Our financial goals are to:

  • Recover capitalization costs;
  • Produce sufficient revenue to allow for a sustainable and scalable publishing program, under continuous development;
  • Bend the publication-charge cost downward over time.

Who will pay the APC?

Corresponding author or Co-authors has to make the payment on acceptance of the article.

When should I pay?

Corresponding author or the paying institutions should arrange for the payment once they are notified regarding acceptance of the article. APC is exempted for cases in which a wavier agreement has been made in-prior to submission.

*We request an immediate attention towards the payment as the articles will not be published unless the charges have been paid.

How do I pay?

Authors or institutions can make payments by two modes as per their convenience.

  1. Wire/Bank transfer
  2. Card payment

Note: No taxes are included in this charge, taxes will be applicable as per the policies of the country of the payee. Additional transaction charges may be levied on the author.

Can I be eligible for wavier on APC?

The waiver request will be considered on a case-by-case basis, and will be provided accordingly.

*The Waiver requests must be made during the submission process and will not be accepted after  processing of the manuscript.

Do I have to pay if my manuscript is rejected?

No, Article processing charges will not be applicable for articles rejected by the Editorial office.

Withdrawal Charges

Are reprints of my article included in the article processing charges (APCs)?

No, Article processing charges (APCs) do not include the charges for the reprints. Reprints facility is optional and should be order separately.

Characteristics of online treatment seekers interested in a text messaging intervention for problem drinking: adults 51 and older versus middle-aged and younger adults.


Liver targeted therapies for hepatocellular carcinoma prior to transplant: contemporary management strategies.


A review of the impact of obesity on common gastrointestinal malignancies


BRCA1 and BRCA2 mutations and treatment strategies for breast cancer


+ More

Most Viewed

Peripheral T-cell lymphoma activation on nivolumab for oesophageal cancer

Ian S Boon Jean S Lim Karen H Williams Kathleen E Romain Tracy PT Au Yong Cheng S Boon

Case Report-Cancer Archives

August 22, 2019


Elaboration of EQID tool for digestive cancer predisposition

Souria Aissaoui Stéphane Pinson Sophie Giraud Marisa Raymond Hagay Sobol Alain Calender

Research article-Cancer Archives

August 25, 2019


Spontaneous regression of angiosarcoma

Mike T Wei Ganesh M Shankar Scott A Ely Roger J Bartolotta Andre-Pascal Sappino David N Posnett

Research Article-Cancer Archives

September 09, 2019


The implication of cancer regression by the interactions with human anatomical axes – an active prevention for cancer

Ming Cheh Ou Dennis Ou Chung Chu Pang

Case Report-Cancer Archives

April 15, 2019


Submit your Next Article

  • Online submission
  • Highly indexed and abstracted
  • 7 years of successful publishing
  • Wider visibility though open access
  • Higher impact with wider visibility
  • Prompt review